로딩 중…
지수 로딩 중…
Daehan Nupharm Co.,Ltd.
054670· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,670-2.58%
2026-06-19
Price Chart
Daehan Nupharm Co.,Ltd.-27.40%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 81.39B KRW |
| Revenue | 205.39B KRW |
| Net Income | 7.48B KRW |
| Total Assets | 275.89B KRW |
| Net Assets | 138.21B KRW |
| Employees | 397 |
| Value | |
| P/E | 10.88x |
| P/B | 0.59x |
| PEG | 0.67x |
| P/S | 0.40x |
| EV/EBITDA | 224.07x |
| FCF Yield | -42.44% |
| Profitability | |
| ROE | 5.41% |
| ROA | 2.71% |
| Op. Margin | 0.60% |
| Revenue Growth | 5.76% |
| Earnings Growth | 16.28% |
| Financial Health | |
| Debt Ratio | 199.62% |
| Total Debt | 213.38B KRW |
| FCF | -34.54B KRW |
| Cash | 18.94B KRW |
| Current Ratio | 1.57x |
| Dividend | |
| Div. Yield | 1.72% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -27.40% |
| 1M Return | -8.40% |
| From 52W High | -35.64% |
| 1Y MDD | -33.17% |
| Trading | |
| Volume | 44,340 shares |
| Foreign Own. | 0.55% |
| Per Share | |
| EPS | 1,092 KRW |
| BPS | 9,847 KRW |
Company Info
Established in 1984 and listed on KOSDAQ in 2002, Daehan Newpharm is a pharmaceutical company headquartered in Hwaseong-si, Gyeonggi-do. It focuses on specialty pharmaceuticals for metabolic diseases like hypertension and diabetes, as well as digestive ulcer treatments, while strengthening non-reimbursable products such as obesity treatments, vitamins, and immune enhancers. The company diversifies into animal pharmaceuticals, developing pet products and farm environment improvers, and expands its bio business into stem cell-based anti-aging agents and cell therapies.